In the APPswe/PS1∆E9 (APP/PS1) transgenic mice administrated with a combination of a high-fat diet and a low-dose injection of streptozotocin, the APSs suppressed metabolic-activated plaque-associated astrocytes and microglia and improved the performance of nest construction in the transgenic AD model (53). Here, APP is linked to Alzheimer disease.